Companies House does not verify the accuracy of the information filed

ENZYVANT THERAPEUTICS HOLDINGS LIMITED

Company number 10317630

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
19 Nov 2024	GAZ1(A)	First Gazette notice for voluntary strike-off	View PDF First Gazette notice for voluntary strike-off - link opens in a new window - 1 page (1 page)
07 Nov 2024	DS01	Application to strike the company off the register	View PDF Application to strike the company off the register - link opens in a new window - 1 page (1 page)
14 Aug 2024	SH19	Statement of capital on 14 August 2024 USD 250.04	View PDF Statement of capital on 14 August 2024 USD 250.04 - link opens in a new window - 3 pages (3 pages)
14 Aug 2024	RESOLUTIONS	Resolutions RES13 ‐ Cancelling share premium account 13/08/2024	View PDF Resolutions RES13 ‐ Cancelling share premium account 13/08/2024 - link opens in a new window - 2 pages (2 pages)
14 Aug 2024	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
14 Aug 2024	CAP-SS	Solvency Statement dated 13/08/24	View PDF Solvency Statement dated 13/08/24 - link opens in a new window - 2 pages (2 pages)
12 Aug 2024	CS01	Confirmation statement made on 8 August 2024 with updates	View PDF Confirmation statement made on 8 August 2024 with updates - link opens in a new window - 4 pages (4 pages)
30 Dec 2023	AA	Accounts for a small company made up to 31 March 2023	View PDF Accounts for a small company made up to 31 March 2023 - link opens in a new window - 18 pages (18 pages)
06 Oct 2023	AP01	Appointment of Ms Emma Carys Price as a director on 6 October 2023	View PDF Appointment of Ms Emma Carys Price as a director on 6 October 2023 - link opens in a new window - 2 pages (2 pages)
06 Oct 2023	TM01	Termination of appointment of Mark Craig as a director on 6 October 2023	View PDF Termination of appointment of Mark Craig as a director on 6 October 2023 - link opens in a new window - 1 page (1 page)
09 Aug 2023	CS01	Confirmation statement made on 8 August 2023 with updates	View PDF Confirmation statement made on 8 August 2023 with updates - link opens in a new window - 4 pages (4 pages)
23 Nov 2022	AA	Accounts for a small company made up to 31 March 2022	View PDF Accounts for a small company made up to 31 March 2022 - link opens in a new window - 18 pages (18 pages)
12 Oct 2022	AD01	Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022	View PDF Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022 - link opens in a new window - 1 page (1 page)
03 Oct 2022	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
03 Oct 2022	SH19	Statement of capital on 3 October 2022 USD 250.04	View PDF Statement of capital on 3 October 2022 USD 250.04 - link opens in a new window - 5 pages (5 pages)
03 Oct 2022	CAP-SS	Solvency Statement dated 21/09/22	View PDF Solvency Statement dated 21/09/22 - link opens in a new window - 2 pages (2 pages)
03 Oct 2022	RESOLUTIONS	Resolutions RES13 ‐ Cancel; share [prem a/c and capital contribution resereve 21/09/2022 RES06 ‐ Resolution of reduction in issued share capital	View PDF Resolutions RES13 ‐ Cancel; share [prem a/c and capital contribution resereve 21/09/2022 RES06 ‐ Resolution of reduction in issued share capital - link opens in a new window - 3 pages (3 pages)
17 Aug 2022	CS01	Confirmation statement made on 8 August 2022 with updates	View PDF Confirmation statement made on 8 August 2022 with updates - link opens in a new window - 4 pages (4 pages)
12 Aug 2022	TM01	Termination of appointment of Sunil Masson as a director on 5 August 2022	View PDF Termination of appointment of Sunil Masson as a director on 5 August 2022 - link opens in a new window - 1 page (1 page)
12 Aug 2022	AP01	Appointment of Mr Mark Craig as a director on 5 August 2022	View PDF Appointment of Mr Mark Craig as a director on 5 August 2022 - link opens in a new window - 2 pages (2 pages)
22 Apr 2022	PSC02	Notification of Sumitomo Pharma Co., Ltd. as a person with significant control on 27 December 2019	View PDF Notification of Sumitomo Pharma Co., Ltd. as a person with significant control on 27 December 2019 - link opens in a new window - 2 pages (2 pages)
22 Apr 2022	PSC09	Withdrawal of a person with significant control statement on 22 April 2022	View PDF Withdrawal of a person with significant control statement on 22 April 2022 - link opens in a new window - 2 pages (2 pages)
08 Apr 2022	SH01	Statement of capital following an allotment of shares on 30 March 2022 USD 25,004	View PDF Statement of capital following an allotment of shares on 30 March 2022 USD 25,004 - link opens in a new window - 3 pages (3 pages)
04 Jan 2022	AA	Accounts for a small company made up to 31 March 2021	View PDF Accounts for a small company made up to 31 March 2021 - link opens in a new window - 19 pages (19 pages)
09 Aug 2021	CS01	Confirmation statement made on 8 August 2021 with updates	View PDF Confirmation statement made on 8 August 2021 with updates - link opens in a new window - 4 pages (4 pages)

Cookies on Companies House services

ENZYVANT THERAPEUTICS HOLDINGS LIMITED

Filter by category